Literature DB >> 12207340

Pulmonary T cells induced by respiratory syncytial virus are functional and can make an important contribution to long-lived protective immunity.

Tobias Ostler1, Stephan Ehl.   

Abstract

The contribution of T cell responses to immunity against respiratory syncytial virus (RSV) is not fully defined, but this is an important issue for vaccine design. Recent studies demonstrating RSV-induced pulmonary T cell suppression suggest that RSV may have evolved strategies to escape T cell immunity. Here we evaluated potential consequences of RSV-mediated immunosuppression for protective memory T cell responses in vivo. Surprisingly, we found strong ex vivo cytolytic activity and interferon production of pulmonary RSV-specific CD8(+) T cells both in the acute and the memory phase of primary murine RSV infection. More significantly, T cell memory made an important contribution to immunity against RSV independent of antibodies. Thus, RSV-primed mice were protected against challenge with RSV-recombinant vaccinia viruses, which can be controlled by RSV-specific T cells, but not by RSV-specific antibodies. In conclusion, RSV does not appear to impair acute and protective memory T cell responses induced by a primary infection. These findings further support that induction of T cell immunity should be a relevant goal for RSV vaccines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12207340     DOI: 10.1002/1521-4141(200209)32:9<2562::AID-IMMU2562>3.0.CO;2-4

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  Regulation of cytokine production by virus-specific CD8 T cells in the lungs.

Authors:  Ross B Fulton; Matthew R Olson; Steven M Varga
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

2.  Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector.

Authors:  Luis Martinez-Sobrido; Negin Gitiban; Ana Fernandez-Sesma; Jerome Cros; Sara E Mertz; Nancy A Jewell; Sue Hammond; Emilio Flano; Russell K Durbin; Adolfo García-Sastre; Joan E Durbin
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.

Authors:  Ki-Hye Kim; Young-Tae Lee; Hye Suk Hwang; Young-Man Kwon; Min-Chul Kim; Eun-Ju Ko; Jong Seok Lee; Youri Lee; Sang-Moo Kang
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

4.  Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration.

Authors:  David J Zammit; Damian L Turner; Kimberly D Klonowski; Leo Lefrançois; Linda S Cauley
Journal:  Immunity       Date:  2006-04       Impact factor: 31.745

5.  Role of T cells in virus control and disease after infection with pneumonia virus of mice.

Authors:  Stefanie Frey; Christine D Krempl; Annette Schmitt-Gräff; Stephan Ehl
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

6.  Localization of the T-cell response to RSV infection is altered in infant mice.

Authors:  Katherine M Eichinger; Jessica L Kosanovich; Kerry M Empey
Journal:  Pediatr Pulmonol       Date:  2017-11-08

Review 7.  The host response and molecular pathogenesis associated with respiratory syncytial virus infection.

Authors:  Christine M Oshansky; Wenliang Zhang; Elizabeth Moore; Ralph A Tripp
Journal:  Future Microbiol       Date:  2009-04       Impact factor: 3.165

8.  Human CD8(+) T Cells Target Multiple Epitopes in Respiratory Syncytial Virus Polymerase.

Authors:  Daniel Burbulla; Patrick S Günther; Janet K Peper; Gerhard Jahn; Kevin M Dennehy
Journal:  Viral Immunol       Date:  2016-04-12       Impact factor: 2.257

9.  Identification of an HLA-A*0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein.

Authors:  Baomei Wang; Huabiao Chen; Xiaodong Jiang; Minghui Zhang; Tao Wan; Nan Li; Xiangyang Zhou; Yanfeng Wu; Feng Yang; Yizhi Yu; Xiaoning Wang; Ruifu Yang; Xuetao Cao
Journal:  Blood       Date:  2004-03-11       Impact factor: 22.113

10.  Pre-existing virus-specific CD8(+) T-cells provide protection against pneumovirus-induced disease in mice.

Authors:  Mary J G van Helden; Peter J S van Kooten; Cornelis P J Bekker; Andrea Gröne; David J Topham; Andrew J Easton; Claire J P Boog; Dirk H Busch; Dietmar M W Zaiss; Alice J A M Sijts
Journal:  Vaccine       Date:  2012-08-29       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.